Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02145156 · ClinicalTrials.gov registry record · NA
Educational Intervention to Minimize Disparities in Humanpapillomavirus Vaccination
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 1,294
- Enrollment target
NCT02145156 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 1,294 participants.
The verdict
NCT02145156, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,294 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate an innovative approach to improving HPV vaccination among the Hispanic population. The clinical objectives/aims of this HPV educational intervention project are to determine: 1. The number of young adults and adolescents in each arm who received any dose of the HPV vaccine during the study period, 2. The number of young adults and adolescents in each arm who initiated the HPV vaccine series during the study period, 3. The number of young adults and adolescents in each arm who initiated but did not complete the HPV vaccine series during the study period, 4. The number of young adults and adolescents in each arm, among all eligible, who completed the HPV vaccine series during the study period, 5. The number of young adults and adolescents in each arm who completed the HPV vaccine series during the study period, among those who initiated the series at study start, and 6. The number of young adults and adolescents in each arm who completed the HPV vaccine series among those who initiated the series during the study period. The implementation of this educational intervention in clinic waiting rooms is intended to assist primary care providers in communicating HPV vaccine awareness and education to parents and patients in a culturally tailored format.
Interventions
- BEHAVIORAL Tailored educational materials
- BEHAVIORAL Untailored educational materials
- BEHAVIORAL Survey-only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,294 participants |
| Start Date | 2014-06 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02145156
The ClinicalTrials.gov registry entry for NCT02145156 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,294 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Tailored educational materials is the first listed.
NCT02145156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02145156 about?
NCT02145156 is a clinical study titled "Educational Intervention to Minimize Disparities in Humanpapillomavirus Vaccination". The purpose of this study is to evaluate an innovative approach to improving HPV vaccination among the Hispanic population. The clinical objectives/aims of this HPV educational intervention project are to determine: 1. The number of young adults and adolescents in each arm who received any dose of ...
What is the current status of trial NCT02145156?
This trial is currently completed. It is a NA study. The enrollment target is 1,294 participants. The study started on 2014-06. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02145156?
The interventions under investigation include: Tailored educational materials (BEHAVIORAL), Untailored educational materials (BEHAVIORAL), Survey-only (BEHAVIORAL).
Who is sponsoring clinical trial NCT02145156?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.